Benzinga | Aug 4, 2020 05:36AM EDT

JP Morgan Downgrades Neurocrine Biosciences to Neutral, Announces $136 Price Target

JP Morgan analyst Anupam Rama downgrades Neurocrine Biosciences (NASDAQ:NBIX) from Overweight to Neutral and announces $136 price target.